Skip to main content
Midas Edge

BIO-PATH HOLDINGS INC

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

BPTH$0.21-66.8%Stored close · as of Feb 18, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Shareholders’ (Deficit) Equity (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY

(in thousands)

​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​
​ · ​ · Common Stock · ​ · Paid in · ​ · Accumulated · ​ · ​
Description · Shares · Amount · Capital · Deficit · Total
​ · ​ · ​ · ​ · ​
Balance at December 31, 2023618​$1​$108,047​$(107,607)​$441
​​​​​​​​
Issuance of common stock and warrants, net of fees and warrant liability136​—​(79)​—​(79)
Stock-based compensation—​—​170​—​170
Net loss—​—​—​(3,157)​(3,157)
​​​​​​​​
Balance at March 31, 2024754​$1​$108,138​$(110,764)​$(2,625)
​​​​​​​​​​​​​​​
​​​​​​​
Balance at December 31, 20245,768​$6​$117,649​$(117,501)​$154
​​​​​​​​​
Exercise of pre-funded warrants, net of fees2,540​2​(1)​—​1
Stock-based compensation—​—​108​—​108
Net loss—​—​—​(2,852)​(2,852)
​​​​​​​​
Balance at March 31, 20258,308​$8​$117,756​$(120,353)​$(2,589)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.